Vasilios Pyrgos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Vasilios Pyrgos has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Judith Veis
§ Section of Nephrology, Washington Hospital Center, Washington
1 shared publicationKathryn Ratanavanich
§ Section of Nephrology, Washington Hospital Center, Washington
1 shared publicationNancy Donegan
† Department of Infection Control, Washington Hospital Center, Washington
1 shared publicationShmuel Shoham
Section of Infectious Diseases, Washington Hospital Center, Washington
1 shared publicationThomas J. Walsh
‡ Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2009
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 47 (5) , 463-467
Candida bloodstream infections in hemodialysis recipients
Candidemia is a major cause of morbidity and mortality in patients undergoing hemodialysis but it has not been well defined in this patient population. We performed a retrospective case-control study to characterize the epidemiology, microbiology, and outcomes of hemodialysis-associated candidemia. All cases of candidemia at our institution were evaluated from 1 January 2000 until 1 September 2004. For each case, two non-candidemic dialysis patients served as controls. Among 350 cases of candidemia, 78 (22%) occurred in adult hemodialysis patients. Cases and controls were similar with respect to age, corticosteroid, antibiotics use, prevalence of diabetes mellitus, liver cirrhosis, surgical procedures, and cancer. Multivariate analysis found total parenteral nutrition (TPN) (19.5% vs. 1.3%; PP=0.0001) to be independently associated with candidemia. Non-C.albicans Candida spp. particularly C. glabrata and C. krusei were more common in hemodialysis recipients than in candidemic patients not receiving hemodialysis (31% vs. 17% p = 0.009). In-hospital mortality was significantly elevated for candidemic vs. non-candidemic hemodialysis recipients (51.9% vs. 7.8%; PC. albicansCandida species, is associated with TPN and dialysis via a vascular catheter (vs. shunt or fistula) and carries a high mortality rate.
- 1 January 2009
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 47 (5) , 463-467
Open AccessCandida bloodstream infections in hemodialysis recipients
Candidemia is a major cause of morbidity and mortality in patients undergoing hemodialysis but it has not been well defined in this patient population. We performed a retrospective case-control study to characterize the epidemiology, microbiology, and outcomes of hemodialysis-associated candidemia. All cases of candidemia at our institution were evaluated from 1 January 2000 until 1 September 2004. For each case, two non-candidemic dialysis patients served as controls. Among 350 cases of candidemia, 78 (22%) occurred in adult hemodialysis patients. Cases and controls were similar with respect to age, corticosteroid, antibiotics use, prevalence of diabetes mellitus, liver cirrhosis, surgical procedures, and cancer. Multivariate analysis found total parenteral nutrition (TPN) (19.5% vs. 1.3%; PP=0.0001) to be independently associated with candidemia. Non-C.albicans Candida spp. particularly C. glabrata and C. krusei were more common in hemodialysis recipients than in candidemic patients not receiving hemodialysis (31% vs. 17% p = 0.009). In-hospital mortality was significantly elevated for candidemic vs. non-candidemic hemodialysis recipients (51.9% vs. 7.8%; PC. albicansCandida species, is associated with TPN and dialysis via a vascular catheter (vs. shunt or fistula) and carries a high mortality rate.